Pharmaceutical company Galenika, one of the largest producers of pharmaceutical products in Serbia and the region, is expanding its business through the acquisition of Lifemedic d.o.o. from Belgrade.

With this transaction, Galenika becomes the owner of the 100% Serbian-Slovenian company Lifemedic and takes over the exclusive distribution of the product program of the renowned Italian pharmaceutical company Pharmalife Research, for the markets of Serbia, Bosnia and Herzegovina, North Macedonia and Montenegro.

The transaction will be completed after the approval process by the antimonopoly commissions in the markets of Serbia, North Macedonia and Montenegro, and is expected at the end of fourth quarter of 2023, after which the process of integration will begin.

“Since becoming a part of the Brazilian NC Group, Galenika has achieved significant business growth and international expansion. The acquisition of the Lifemedic company and the start of cooperation with the Italian manufacturer Pharmalife Research represents another step in the internationalization of Galenika’s business and confirms our full commitment to investments and innovations in accordance with the modern needs of consumers,” said Ricardo Vian Marques, CEO of Galenika.